Clinical Trial Update: Nanodiamond-Gutta Percha Composite Biomaterials for Root Canal Therapy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating nanodiamond-gutta percha composite biomaterials for root canal therapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Pulp Diseases
• Dental Pulp Necrosis

Drugs mentioned

• Nanodiamond-Gutta Percha Composite Biomaterials

Snippet

Sponsor: University of California, Los Angeles | Conditions: Dental Pulp Diseases, Dental Pulp Necrosis | Phase 2, Phase 3 | Status: WITHDRAWN